- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/38 - Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Patent holdings for IPC class C07D 213/38
Total number of patents in this class: 657
10-year publication summary
50
|
42
|
39
|
56
|
36
|
46
|
26
|
36
|
28
|
19
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Samsung Display Co., Ltd. | 34641 |
16 |
Molecular Insight Pharmaceuticals, Inc. | 55 |
14 |
Centre National de La Recherche Scientifique | 10421 |
13 |
Bristol-myers Squibb Company | 4878 |
12 |
Merck Patent GmbH | 5830 |
9 |
The Governing Council of The University of Toronto, | 1475 |
9 |
Genentech, Inc. | 3971 |
8 |
Novartis AG | 10847 |
7 |
Atrogi AB | 52 |
7 |
Gilead Sciences, Inc. | 2037 |
7 |
Institut Curie | 582 |
7 |
Oryzon Genomics S.A. | 106 |
7 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3145 |
7 |
The Regents of the University of California | 19898 |
6 |
The Johns Hopkins University | 5667 |
6 |
Ardelyx, Inc. | 113 |
6 |
Universite de Montpellier | 986 |
6 |
Mycovia Pharmaceuticals, Inc. | 41 |
6 |
Shaanxi Lighte Optoelectronics Material Co., Ltd. | 257 |
6 |
Mayo Foundation for Medical Education and Research | 3204 |
5 |
Other owners | 493 |